Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
52,966,709
-
Share change
-
-1,241,122
-
Total reported value
-
$383,993,662
-
Put/Call ratio
-
98%
-
Price per share
-
$7.25
-
Number of holders
-
231
-
Value change
-
-$13,671,500
-
Number of buys
-
97
-
Number of sells
-
98
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2023
As of 31 Mar 2023,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
231 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,966,709 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, Woodline Partners LP, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, JPMORGAN CHASE & CO, and PICTET ASSET MANAGEMENT SA.
This page lists
231
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.